• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带者筛查与囊性纤维化发病率的关系。

Association between carrier screening and incidence of cystic fibrosis.

机构信息

Cystic Fibrosis Center, Verona Hospital, Piazzale Stefani 1, 37126 Verona, Italy.

出版信息

JAMA. 2009 Dec 16;302(23):2573-9. doi: 10.1001/jama.2009.1758.

DOI:10.1001/jama.2009.1758
PMID:20009057
Abstract

CONTEXT

A downward trend in cystic fibrosis (CF) birth incidence has been reported in some areas.

OBJECTIVE

To evaluate the association between carrier screening and CF birth incidence.

DESIGN, SETTING, AND PARTICIPANTS: In northeastern Italy, CF birth incidence is monitored by means of a long-standing neonatal screening program. In the same area, 2 sections using different carrier detection approaches were identified--the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilization; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age. A total of 779,631 newborns underwent CF neonatal screening between January 1993 and December 2007, of whom 195 had CF detected.

MAIN OUTCOME MEASURE

Cystic fibrosis birth incidence in the 2 regions.

RESULTS

A time-related decrease in birth incidence was found, with a mean annual percentage decrease of 0.16 per 10,000 neonates (P < .001). In the western region, 2559 carrier tests were performed, 314 carriers were identified, and 9 carrier couples were detected. In the eastern region, 87,025 carrier tests were performed, 3650 carriers were identified, and 82 carrier couples were detected. The birth rate decrease was greater in the eastern region (decrease rate, 0.24; 95% confidence interval [CI], 0.12-0.36) than in the western region (decrease rate, 0.04; 95% CI, -0.16 to 0.08; P = .01). The increase in the number of screened carriers over time was significantly correlated with the decrease in CF birth incidence (correlation coefficient = -0.53; 95% CI, -0.20 to -0.74; P = .003).

CONCLUSION

In northeastern Italy, carrier screening was associated with a decrease in the incidence of CF.

摘要

背景

在一些地区,囊性纤维化(CF)的出生率呈下降趋势。

目的

评估携带者筛查与 CF 出生率之间的关系。

设计、地点和参与者:在意大利东北部,CF 的出生率通过一项长期的新生儿筛查计划进行监测。在同一地区,确定了两个使用不同携带者检测方法的区域——西部地区,仅向患者的亲属或计划进行体外受精的夫妇提供 CF 携带者检测;以及东部地区,向亲属提供携带者检测,向不孕夫妇和育龄夫妇提供携带者筛查。共有 779631 名新生儿在 1993 年 1 月至 2007 年 12 月期间接受了 CF 新生儿筛查,其中 195 名被检出患有 CF。

主要观察指标

两个地区的 CF 出生率。

结果

发现出生率呈时间相关下降,每 10000 名新生儿的年平均百分比下降 0.16(P<.001)。在西部地区,进行了 2559 次携带者检测,发现 314 名携带者,发现 9 对携带者夫妇。在东部地区,进行了 87025 次携带者检测,发现 3650 名携带者,发现 82 对携带者夫妇。东部地区的出生率下降幅度大于西部地区(下降率为 0.24;95%置信区间[CI],0.12-0.36)(下降率为 0.04;95%CI,-0.16 至 0.08;P=0.01)。随着时间的推移,筛查携带者的数量增加与 CF 出生率下降显著相关(相关系数=-0.53;95%CI,-0.20 至-0.74;P=0.003)。

结论

在意大利东北部,携带者筛查与 CF 发病率的下降有关。

相似文献

1
Association between carrier screening and incidence of cystic fibrosis.携带者筛查与囊性纤维化发病率的关系。
JAMA. 2009 Dec 16;302(23):2573-9. doi: 10.1001/jama.2009.1758.
2
Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.对囊性纤维化携带者进行全社区筛查可替代新生儿筛查来诊断囊性纤维化。
J Paediatr Child Health. 2007 Nov;43(11):721-3. doi: 10.1111/j.1440-1754.2007.01224.x.
3
Cystic fibrosis carrier screening effects on birth prevalence and newborn screening.囊性纤维化携带者筛查对出生患病率和新生儿筛查的影响。
Genet Med. 2016 Feb;18(2):145-51. doi: 10.1038/gim.2015.68. Epub 2015 Jun 18.
4
A 10-year large-scale cystic fibrosis carrier screening in the Italian population.意大利人群中一项长达 10 年的大型囊性纤维化携带者筛查。
J Cyst Fibros. 2010 Jan;9(1):29-35. doi: 10.1016/j.jcf.2009.10.003. Epub 2009 Nov 7.
5
Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.维多利亚州基于人群的囊性纤维化携带者筛查:头三年的经验。
Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):484-9. doi: 10.1111/j.1479-828X.2009.01045.x.
6
Carrier screening for cystic fibrosis.囊性纤维化携带者筛查。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):47-59, Table of Contents. doi: 10.1016/j.ogc.2010.02.002.
7
Population-based genetic screening for cystic fibrosis: attitudes and outcomes.基于人群的囊性纤维化基因筛查:态度与结果
Public Health Genomics. 2010;13(7-8):449-56. doi: 10.1159/000276544. Epub 2010 Jan 14.
8
An update on cystic fibrosis screening.囊性纤维化筛查的最新情况。
Clin Lab Med. 2010 Sep;30(3):533-43. doi: 10.1016/j.cll.2010.04.005.
9
Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.爱沙尼亚对囊性纤维化主要突变ΔF508进行新生儿筛查。
J Med Screen. 1998;5(1):16-9. doi: 10.1136/jms.5.1.16.
10
Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.公共卫生策略对法国布列塔尼地区囊性纤维化出生患病率的影响。
Hum Genet. 2003 Aug;113(3):280-5. doi: 10.1007/s00439-003-0962-0. Epub 2003 May 27.

引用本文的文献

1
Special Issue "Research Advances on Cystic Fibrosis and CFTR Protein".特刊“囊性纤维化与CFTR蛋白的研究进展”
Int J Mol Sci. 2025 Jul 13;26(14):6708. doi: 10.3390/ijms26146708.
2
Next-Generation Sequencing for Screening Analysis of Cystic Fibrosis: Spectrum and Novel Variants in a South-Central Italian Cohort.下一代测序在囊性纤维化筛查分析中的应用:意大利中南部队列的频谱和新变异。
Genes (Basel). 2023 Aug 11;14(8):1608. doi: 10.3390/genes14081608.
3
Multilevel barriers and facilitators to widespread use of preconception carrier screening in the United States.
多层面的障碍和促进因素阻碍了美国广泛使用孕前携带者筛查。
Genet Med. 2023 Dec;25(12):100946. doi: 10.1016/j.gim.2023.100946. Epub 2023 Jul 30.
4
Contemporary cystic fibrosis incidence rates in Canada and the United States.加拿大和美国当代囊性纤维化发病率。
J Cyst Fibros. 2023 May;22(3):443-449. doi: 10.1016/j.jcf.2022.10.008. Epub 2022 Nov 10.
5
Association of Patient and Site-of-Care Characteristics With Reproductive Carrier Screening Timing in a Large Integrated Health System.在一个大型综合医疗系统中,患者和护理地点特征与生殖携带者筛查时机的关联。
JAMA Netw Open. 2022 Nov 1;5(11):e2240829. doi: 10.1001/jamanetworkopen.2022.40829.
6
mutations causing congenital unilateral absence of the vas deferens (CUAVD) and congenital absence of the uterus (CAU) in a consanguineous family.导致先天性单侧输精管缺失(CUAVD)和先天性子宫缺失(CAU)的突变在一个近亲家庭中。
Asian J Androl. 2022 Jul-Aug;24(4):416-421. doi: 10.4103/aja202177.
7
Genes Regulating Spermatogenesis and Sperm Function Associated With Rare Disorders.与罕见疾病相关的调控精子发生和精子功能的基因
Front Cell Dev Biol. 2021 Feb 16;9:634536. doi: 10.3389/fcell.2021.634536. eCollection 2021.
8
Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable.囊性纤维化的早期诊断与干预:想象不可想象之事。
Front Pediatr. 2021 Jan 11;8:608821. doi: 10.3389/fped.2020.608821. eCollection 2020.
9
Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017.通过新生儿筛查发现的先天性疾病患儿 - 美国,2015-2017 年。
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1265-1268. doi: 10.15585/mmwr.mm6936a6.
10
The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the Gene Discovery.囊性纤维化的流行情况变化:基因发现的发生率、生存率和影响。
Genes (Basel). 2020 May 26;11(6):589. doi: 10.3390/genes11060589.